Stockreport

Eli Lilly: Retatrutide Justifies Hype With Best Weight Loss Data Yet - I'm Sold [Seeking Alpha]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Retatrutide achieved up to 28.7% average weight loss and significant pain reduction, surpassing analyst expectations and rival offerings. Despite a high P/E of 50x an [Read more]